Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells

Clinical and Experimental Immunology

Volumn 176, Issue 2, 2014, Pages 180-189

  Kalantari, T ^a,d   Karimi, M H ^b   Ciric, B ^d   Yan, Y ^d   Rostami, A ^d   Kamali Sarvestani, E ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

CD40; Dendritic cell; IL 23p19; Lentiviral vector; RNAi

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 6; LENTIVIRUS VECTOR; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SHORT HAIRPIN RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA SYNTHESIS; DOWN REGULATION; IN VITRO STUDY; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; T LYMPHOCYTE; TH17 CELL;

CD40; DENDRITIC CELL; IL-23P19; LENTIVIRAL VECTOR; RNAI;

ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; LENTIVIRUS; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TH17 CELLS; TREATMENT OUTCOME;

EID: 84897942523     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12266     Document Type: Article

References (42)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372:1502-1517.
2. Vaknin-Dembinsky A, Balashov K, Weiner HL. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 2006; 176:7768-7774.
3. Harrington LE, Hatton RD, Mangan PR etal. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-1132.
4. Langrish CL, Chen Y, Blumenschein WM etal. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-240.
5. Park H, Li Z, Yang XO etal. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133-1141.
6. Bradshaw EM, Raddassi K, Elyaman W etal. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009; 183:4432-4439.
7. Seki M, Oomizu S, Sakata K-M etal. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008; 127:78-88.
8. Durelli L, Conti L, Clerico M etal. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β. Ann Neurol 2009; 65:499-509.
9. Batten M, Li J, Yi S etal. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7:929-936.
10. Segura E, Touzot M, Bohineust A etal. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013; 38:336-348.
11. Perona-Wright G, Jenkins SJ, O'Connor RA etal. A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo. J Immunol 2009; 182:2808-2815.
12. Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ, Kopf M. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc Natl Acad Sci USA 2009; 106:876-881.
13. Bettelli E, Carrier Y, Gao W etal. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238.
14. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-189.
15. Mangan PR, Harrington LE, O'Quinn DB etal. Transforming growth factor-β induces development of the TH17 lineage. Nature 2006; 441:231-234.
16. Korn T, Bettelli E, Gao W etal. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 2007; 448:484-487.
17. Nurieva R, Yang XO, Martinez G etal. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448:480-483.
18. Zhou L, Ivanov II, Spolski R etal. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8:967-974.
19. Grimm D, Kay MA. RNAi and gene therapy: a mutual attraction. Hematology Am Soc Hematol Educ Program 2007; 2007:473-481.
20. Fu W, Zhu J, Qiu Y, Li W. Induction of CD4+CD25+ T cells and control of cardiac allograft rejection by CD40/CD40L costimulatory pathway blockade in mice. Transplant Proc 2013; 45:611-617.
21. Wang B, Qian H, Yang H, Xu L, Xu W, Yan J. Regression of atherosclerosis plaques in apolipoprotein E(-)/(-) mice after lentivirus-mediated RNA interference of CD40. Int J Cardiol 2013; 163:34-39.
22. Suzuki M, Zheng X, Zhang X etal. A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol 2010; 125:737-743. e736.
23. Zheng X, Suzuki M, Ichim TE etal. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells. J Immunol 2010; 184:6457-6464.
24. Li Y, Sun M, Cheng H etal. Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice. Exp Mol Med 2011; 43:197-204.
25. Inaba K, Steinman RM, Pack MW etal. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992; 175:1157-1167.
26. Koch F, Stanzl U, Jennewein P etal. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184:741-746.
27. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192:1213-1222.
28. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
29. Mackey MF, Barth R, Noelle RJ. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 1998; 63:418-428.
30. Cho M-L, Kang J-W, Moon Y-M etal. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 2006; 176:5652-5661.
31. Caux C, Massacrier C, Vanbervliet B etal. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180:1263-1272.
32. McLellan AD, Starling GC, Williams LA, Hock BD, Hart DN. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur J Immunol 1995; 25:2064-2068.
33. Krajina T, Leithäuser F, Möller P, Trobonjaca Z, Reimann J. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur J Immunol 2003; 33:1073-1083.
34. Chen Y, Langrish CL, McKenzie B etal. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006; 116:1317-1326.
35. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173-6177.
36. Weyand CM, Younge BR, Goronzy JJ. IFN-γ and IL-17-the two faces of T cell pathology in giant cell arteritis. Curr Opin Rheumatol 2011; 23:43-49.
37. Zheng X, Suzuki M, Zhang X etal. RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis. Arthritis Res Ther 2010; 12:R13.
38. Yen D, Cheung J, Scheerens H etal. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310-1316.
39. Anderson AE, Sayers BL, Haniffa MA etal. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 2008; 84:124-133.
40. Hilkens CM, Isaacs JD, Thomson AW. Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol 2010; 29:156-183.
41. Gao J, Madrenas J, Zeng W etal. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology 1999; 98:159-170.
42. El-Behi M, Ciric B, Dai H etal. The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011; 12:568-575.